Laura Sandler, the Chief Operating Officer of Oruka Therapeutics, has executed a sale of shares in the company, amounting to $319,384. This transaction reflects her decision to divest a portion of her holdings in Orka. The sale is part of her financial management strategy and is consistent with regulatory disclosures regarding insider trading activities. Further details regarding the timing and specific number of shares sold have not been disclosed.
Related Articles
Don't miss out on breaking stories and in-depth articles.